NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.
暂无分享,去创建一个
C. Y. Wang | M. Mayo | Cun-Yu Wang | L. Madrid | A. Baldwin | D. Guttridge
[1] R. Cooper,et al. In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. , 1999, Journal of cell science.
[2] Chris Albanese,et al. NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.
[3] J. Beckmann,et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A , 1999, Nature Medicine.
[4] F. López‐Soriano,et al. The role of cytokines in cancer cachexia , 1999, Medicinal research reviews.
[5] M. Tisdale. Biology of cachexia. , 1997, Journal of the National Cancer Institute.
[6] E. Duda,et al. TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin. , 1997, European journal of cell biology.
[7] P. Silver,et al. MyoD is required for myogenic stem cell function in adult skeletal muscle. , 1996, Genes & development.
[8] M. Zhang,et al. MyoD protein accumulates in satellite cells and is neurally regulated in regenerating myotubes and skeletal muscle fibers , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.
[9] T. Maniatis,et al. NF-κB: A lesson in family values , 1995, Cell.
[10] A. Lassar,et al. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. , 1994, Current opinion in cell biology.
[11] M. Rudnicki,et al. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development , 1992, Cell.
[12] A. Oliff,et al. Tumors secreting human TNF/cachectin induce cachexia in mice , 1987, Cell.
[13] T. Ogihara,et al. Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model , 1999, Gene Therapy.
[14] B. Black,et al. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.
[15] M J May,et al. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.
[16] A. Baldwin,et al. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .
[17] K. Tracey,et al. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. , 1994, Annual review of medicine.
[18] J. Eys. Nutrition and cancer: physiological interrelationships. , 1985, Annual review of nutrition.